We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China Ramps Up Inspections at Foreign Drug Plants
Just as the U.S. Food and Drug Administration is ramping up inspections in China, Chinese regulators are increasing their oversight of overseas manufacturing operations, conducting 30 inspections so far in 2015.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor